Cargando…
Expression of Concern: Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
Formato: | Online Artículo Texto |
---|---|
Lenguaje: | English |
Publicado: |
Portland Press Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9334752/ https://www.ncbi.nlm.nih.gov/pubmed/35892312 http://dx.doi.org/10.1042/BSR-2019-4030_EOC |
Ejemplares similares
-
Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
por: Zhang, Xiong, et al.
Publicado: (2020) -
Retraction: Dexmedetomidine postconditioning suppresses myocardial ischemia/reperfusion injury by activating the SIRT1/mTOR axis
Publicado: (2022) -
Expression of concern: Compensatory increase of transglutaminase 2 is responsible for resistance to mTOR inhibitor treatment
Publicado: (2020) -
Expression of concern: MicroRNA-140-5p suppresses retinoblastoma cell growth via inhibiting c-Met/AKT/mTOR pathway
Publicado: (2020) -
Expression of Concern: Suppression of microRNA-135b-5p protects
against myocardial ischemia/reperfusion injury by activating JAK2/STAT3
signaling pathway in mice during sevoflurane anesthesia
Publicado: (2021)